c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid

Chinese Medical Journal

Volumn 113, Issue 9, 2000, Pages 823-826

  Jiang, Ning ^a   Zhan, Fenghuang ^a   Cao, Li ^a   Yao, Kaitai ^a   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

c myc; Nasopharyngeal carcinoma cell; Retinoic acid

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYRIBONUCLEASE I; DNA; MESSENGER RNA; RETINOIC ACID;

ARTICLE; CELL CULTURE; CELL DIVISION; CELL SIZE; DOSE RESPONSE; DRUG EFFECT; GENE SILENCING; GENETICS; HUMAN; METABOLISM; NASOPHARYNX TUMOR; ONCOGENE MYC; PATHOLOGY; TIME;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL SIZE; DEOXYRIBONUCLEASE I; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE SILENCING; GENES, MYC; HUMANS; NASOPHARYNGEAL NEOPLASMS; RNA, MESSENGER; TIME FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034285558     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Breitman TR, Selonick SE, Collins SJ, et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad USA 1980;77:2936-2940.
2. Lotan R, Nicolson GL. Heterogeneity in growth inhibition by beta-trans-retinoic acid of metastatic B16 melanoma clones and in vivo-selected cell variant lines. Cancer Res 1979;39:4767-4771.
3. Grunt TW, Somay C, Paveika M, et al. The effects of dimethyl sulfoxide and retinoic acid on the cell growth and the phenotype of ovarian cancer cells. J Cell Sci 1991;100:657-666.
4. Lachman HM, Hatton KS, Skoultchi AI, et al. c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment. Proc Natl Acad U S A 1985;82:5323-5327.
5. Thiele CL, Reynolds CP, Israel MA. Decreased expression of N-myc precedes retinoic acid induced morphological differentiation of human neuroblastoma. Nature 1985;313:404-406.
6. Siebenlist U, Hennighausen L, Battey J, et al. Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell 1984;37:381-391.
7. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989;7.39-7.52 9.16-9.52
8. Puck TT, Krystosek A. Role of cytoskeleton in genome regulation and cancer. Inter Rev Cytol 1992;132:75-108.
9. Dyson PJ, Rabbits TH. Chromatin structure around the c-myc gene in Burkitt lympomas with upstream and downstream translocation points. Proc Natl Acad Sci U S A 1985;82:1984-1988.
10. Bentley DL, Groudine M. Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas. Mol Cell Biol 1986;6:3481-3489.
11. Dyson PJ, Littlewood TD, Forster A. Chromatin structure of transcriptionally active and inactive human c-myc alleles. EMBO J 1985;4:2885-2891.
12. High KA, Stolle CA, Schneider JW, et al. c-myc gene inactivation during induced maturation of HL 60 cell. Transcriptional repression and loss of a specific DNase- I hypersensitive site. J Clin Invest 1987;79:93-99.
13. Kumar S, Leffak M. Conserved chromatin structure in c-myc 5'flanking DNA after viral transduction. J Mol Biol 1991;222:45-57.
14. Bentley DL, Groudine M. A block to elongation is largely responsible for decreased transcription of c-myc in HL 60 cells. Nature 1986;321:702-706.
15. Siebenlist U, Bressler P, Kelly K. Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL 60 cells. Mol Cell Biol 1988;8:867-874.